Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

A cure for AIDS?

Genetic engineering may hold the key to curing AIDS.

Once inside the body, the often-lethal HIV virus that causes AIDS is hard to stamp out, partly because the virus incorporates itself into the genes of normal cells. That makes it hard to target with conventional drugs.

Now a research team at Temple University has engineered a way to get hold of those cells and prevent them from reproducing.

Using gene-editing technology known as CRISPR, the team delivered genes to the HIV virus’ DNA that make it impossible for HIV genes to reproduce.

In tests in mice, the technique eliminated 60 percent to 95 percent of the HIV virus.

TRENDPOST: Years of testing and refinement lie ahead for this approach to curing AIDS. Meanwhile, the method opens a new pathway for similar research that may speed us to an AIDS cure by 2050.

Comments are closed.